A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease

NCT01075763 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Interferon beta-1a
DRUG: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]